Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies

Wang, Yin, Liu, Yan, Malek, Sami N., Zheng, Pan, Liu, Yang·2011·Cell stem cell
DOI 10.1016/j.stem.2011.02.006

Cited by (410)

Items 201–300 of 410

  1. At the crossroads of cancer stem cells and targeted therapy resistance
    Anbang Wang, Le Qu, Linhui Wang · 2016 · Cancer Letters
  2. HIF1α-mediated transactivation of WTAP promotes AML cell proliferation via m6A-dependent stabilization of KDM4B mRNA
    Yang-Liu Shao, Yu-Qing Li, Mengyue Li, Lili Wang, Hui-Sheng Zhou, Dai‐Hong Liu, Li Yu, Ji Lin, Xiaoning Gao · 2023 · Leukemia
  3. Role of HDAC3-miRNA-CAGE Network in Anti-Cancer Drug-Resistance
    Yoojung Kwon, Youngmi Kim, Hyun Suk Jung, Dooil Jeoung · 2018 · International Journal of Molecular Sciences
  4. Targeting Leukemia Stem Cell-Niche Dynamics: A New Challenge in AML Treatment
    PAOLO P. BERNASCONI, Oscar Borsani · 2019 · Journal of Oncology
  5. Unlocking the Secrets of Cancer Stem Cells with γ-Secretase Inhibitors: A Novel Anticancer Strategy
    Maryam Ghanbari-Movahed, Zahra Ghanbari‐Movahed, Saeideh Momtaz · 2021 · Molecules
  6. The Complexity of the Tumor Microenvironment and Its Role in Acute Lymphoblastic Leukemia: Implications for Therapies
    Carolina Simioni, Ilaria Conti, Gabriele Varano · 2021 · Frontiers in Oncology
  7. Role of nitric oxide in the maintenance of pluripotency and regulation of the hypoxia response in stem cells
    Amparo Beltrán-Povea · 2015 · World Journal of Stem Cells
  8. Effect of hypoxia-inducible factors in normal and leukemic stem cell regulation and their potential therapeutic impact
    Kevin Rouault‐Pierre, Ashley Hamilton, Dominique A. Bonnet · 2015 · Expert Opinion on Biological Therapy
  9. Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer
    A. Chávez-González, Babak Bakhshinejad, Katayoon Pakravan, M. Guzman, S. Babashah · 2016 · Cellular Oncology
  10. Differential hypoxic regulation of the microRNA-146a/CXCR4 pathway in normal and leukemic monocytic cells: impact on response to chemotherapy
    Isabella Spinello, Maria Teresa Quaranta, Rosa Paolillo, Elvira Pelosi, Annamaria Cerio, Ernestina Saulle, F. L. Coco, Ugo Testa, Catherine Labbaye · 2015 · Haematologica
  11. HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies
    Saima Subhani, Divya Teja Vavilala, Mridul Mukherji · 2016 · Angiogenesis
  12. Characterization of gastric cancer stem-like molecular features, immune and pharmacogenomic landscapes
    Chen Wei, Mingkai Chen, Wenying Deng, Liangyu Bie, Yijie Ma, Chi Zhang, Kangdong Liu, Wei Shen, Shuyi Wang, Chaogang Yang et al. · 2021 · Briefings in Bioinformatics
  13. Evaluation of Anti-HIF and Anti-Angiogenic Properties of Honokiol for the Treatment of Ocular Neovascular Diseases
    Divya Teja Vavilala, V. K. Chaithanya Ponnaluri, D. Kanjilal, Mridul Mukherji · 2014 · PLoS ONE
  14. Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinic
    Muneera Al-Hussaini, John F. DiPersio · 2014 · Expert Review of Hematology
  15. Targeting Leukemia Stem Cells: Which Pathways Drive Self-Renewal Activity in T-Cell Acute Lymphoblastic Leukemia?
    Miriam Belmonte, Catherine Hoofd, Andrew P. Weng, Vincenzo Giambra · 2016 · Current Oncology
  16. Gli1 expression in cancer stem-like cells predicts poor prognosis in patients with lung squamous cell carcinoma
    Yan Ru Cui, Chunai Cui, Zhaoting Yang, Wei-dong Ni, Yu Jin, Yanhua Xuan · 2017 · Experimental and Molecular Pathology
  17. HIF‐1α/Actl6a/H3K9ac axis is critical for pluripotency and lineage differentiation of human induced pluripotent stem cells
    Peng Cui, Ping Zhang, Yanmin Zhang, Lihua Sun, Guanghui Cui, Xin Guo, He Wang, Xiaowei Zhang, Yu Shi, Zhendong Yu · 2020 · The FASEB Journal
  18. Anaerobicizing into Pluripotency
    Athanasia D. Panopoulos, Juan Carlos Izpisúa Belmonte · 2011 · Cell Metabolism
  19. Can immunotherapy specifically target acute myeloid leukemic stem cells?
    Sylvia Snauwaert, Bart Vandekerckhove, Tessa C. C. Kerre · 2013 · OncoImmunology
  20. Biology of the bone marrow microenvironment and myelodysplastic syndromes
    Erinn B. Rankin, Anupama Narla, Joseph K. Park, Shuo Lin, Kathleen M. Sakamoto · 2015 · Molecular Genetics and Metabolism
  21. NOTCH signaling roles in acute myeloid leukemia cell growth and interaction with other stemness-related signals.
    Shuji Tohda · 2014 · PubMed
  22. Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor
    Yan Liu, Marie V. Nelson, Christopher M. Bailey, Peng Zhang, Pan Zheng, Jeffrey S. Dome, Yang Liu, Yin Wang · 2021 · Oncogene
  23. Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors
    Sandra Muñoz-Galván, Eva M. Verdugo‐Sivianes, José M. Santos-Pereira, Purificación Estévez-García, Amancio Carnero · 2024 · Journal of Experimental & Clinical Cancer Research
  24. Comparison of 18F-Fluoroazomycin-Arabinofuranoside and 64Cu-Diacetyl-Bis(N4-Methylthiosemicarbazone) in Preclinical Models of Cancer
    Silvia Valtorta, Sara Belloli, Francesca Sanvito · 2013 · Journal of Nuclear Medicine
  25. Evaluation of Curcumin, a Natural Product in Turmeric, on Burkitt Lymphoma and Acute Myeloid Leukemia Cancer Stem Cell Markers
    Yanyan Li, Aaron M. Domina, Gi Lim · 2018 · Future Oncology
  26. Obesity Impairs Embryonic Myogenesis by Enhancing BMP Signaling within the Dermomyotome
    Liang Zhao, Nathan C. Law, Noe Alberto Gomez, Junseok Son, Yao Gao, Xiangdong Liu, Jeanene Marie de Avila, Meijun J. Zhu, ‬Min Du · 2021 · Advanced Science
  27. Loss of miR-31-5p drives hematopoietic stem cell malignant transformation and restoration eliminates leukemia stem cells in mice
    Biying Zhu, Wenbin Zhong, Xiuye Cao, Guoping Pan, Meng‐Yang Xu, Jie Zheng, Huanzhao Chen, Xiaoqin Feng, Chengwei Luo, Chen Lu et al. · 2022 · Science Translational Medicine
  28. Extracellular-signal-regulated kinase 5 modulates the antioxidant response by transcriptionally controlling Sirtuin 1 expression in leukemic cells
    Nuria López-Royuela, Moeez Ghani Rathore, Nerea Allende-Vega, Jean‐Sébastien Annicotte, Lluis Fajas A, Bindu Ramachandran, Tod Gulick, Martín Villalba · 2014 · The International Journal of Biochemistry & Cell Biology
  29. A HIF-1 network reveals characteristics of epithelial-mesenchymal transition in acute promyelocytic leukemia
    Stefano Percio, Nadia Coltella, Sara Grisanti, Rosa Bernardi, Linda Pattini · 2014 · Genome Medicine
  30. Radioresistance and Cancer Stem Cells: Survival of the Fittest
    Lei Sun · 2011 · Journal of Carcinogenesis & Mutagenesis
  31. Targeting acute myeloid leukemia stem cells: Current therapies in development and potential strategies with new dimensions
    Yuxin Tan, Qiuji Wu, Fuling Zhou · 2020 · Critical Reviews in Oncology/Hematology
  32. Metabolic crosstalk between stromal and malignant cells in the bone marrow niche
    Hernán A. Tirado, Nithya Balasundaram, Lotfi Laaouimir, Ayşegül Erdem, Nick van Gastel · 2023 · Bone Reports
  33. MEIS inhibitors reduce the viability of primary leukemia cells and Stem cells by inducing apoptosis
    Neslihan Meriç, Esra Albayrak, Zafer Gülbaş, Fatih Kocabaş · 2023 · Leukemia & lymphoma/Leukemia and lymphoma
  34. Therapeutically targeting SELF‐reinforcing leukemic niches in acute myeloid leukemia: A worthy endeavor?
    P. Bernasconi, M. Farina, M. Boni, Irene Dambruoso, C. Calvello · 2016 · American journal of hematology/oncology
  35. Noncanonical roles of p53 in cancer stemness and their implications in sarcomas
    Lucie Curylova, Helena Ramos, Lucı́lia Saraiva, Jan Skoda · 2021 · Cancer Letters
  36. Meis1 supports leukemogenesis through stimulation of ribosomal biogenesis and Myc
    María-Paz García-Cuéllar, Andreas Prinz, Robert K. Slany · 2022 · Haematologica
  37. Loss of HIF-1α accelerates murine FLT-3ITD-induced myeloproliferative neoplasia
    Talía Velasco-Hernández, Daniel Tornero, Jörg Cammenga · 2015 · Leukemia
  38. Deferasirox selectively induces cell death in the clinically relevant population of leukemic CD34+CD38– cells through iron chelation, induction of ROS, and inhibition of HIF1α expression
    Saar Shapira, Pia Raanani, Aladin Samara, Arnon Nagler, Ido Lubin, Nadir Arber, Galit Granot · 2018 · Experimental Hematology
  39. Long Non-Coding RNA Taurine Upregulated Gene 1 Targets miR-185 to Regulate Cell Proliferation and Glycolysis in Acute Myeloid Leukemia Cells in vitro
    Weide Zhang, Yuhua Liu, Jing Zhang · 2020 · OncoTargets and Therapy
  40. Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio
    Marike W. van Gisbergen, Emma Zwilling, Ludwig Jerome Dubois · 2021 · Frontiers in Oncology
  41. Relevance of leukemic stem cells in acute myeloid leukemia: heterogeneity and influence on disease monitoring, prognosis and treatment design
    Rolf Wouters, David G. J. Cucchi, Gertjan J.L. Kaspers, Gerrit Jan Schuurhuis, Jacqueline J Cloos · 2014 · Expert Review of Hematology
  42. Hypoxia-Like Signatures Induced by BCR-ABL Potentially Alter the Glutamine Uptake for Maintaining Oxidative Phosphorylation
    Pallavi Sontakke, Katarzyna M. Koczula, Jennifer Jaques, Albertus T.J. Wierenga, Annet Z. Brouwers-Vos, Maurien G. M. Pruis, Ulrich L. Günther, Edo Vellenga, Jan Jacob Schuringa · 2016 · PLoS ONE
  43. Hypoxia inducible factor-1α regulates a pro-invasive phenotype in acute monocytic leukemia
    Jessica Migliavacca, Stefano Percio, Roberta Valsecchi, Elisabetta Ferrero, Antonello Enrico Spinelli, Maurilio Ponzoni, Cristina Tresoldi, Linda Pattini, Rosa Bernardi, Nadia Coltella · 2016 · Oncotarget
  44. Emetine induces chemosensitivity and reduces clonogenicity of acute myeloid leukemia cells
    Josep María Cornet-Masana, Daniel Moreno-Martínez, María Carmen Lara-Castillo, Meritxell Nomdedéu, Amaia Etxabe, Niccoló Tesi, Marta Pratcorona, Jordi Esteve, Ruth M. Risueño · 2016 · Oncotarget
  45. Cited2 in hematopoietic stem cell function
    Jinwei Du, Yu‐Chung Yang · 2013 · Current Opinion in Hematology
  46. The hypoxic microenvironment: A determinant of cancer stem cell evolution
    Amancio Carnero, Matilde Esther LLeonart · 2015 · Inside the Cell
  47. Evaluating ivosidenib for the treatment of relapsed/refractory AML: design, development, and place in therapy
    Samah Nassereddine, Coen Johannes Gerardus Lap, Imad A. Tabbara · 2018 · OncoTargets and Therapy
  48. High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma
    Cheng‐Han Lin, Hao‐Yi Li, Yu‐Peng Liu, Pei-Fung Kuo, Wen‐Ching Wang, Forn‐Chia Lin, Wei-Lun Chang, Bor‐Shyang Sheu, Yi‐Ching Wang, Wan-Chun Hung et al. · 2019 · Therapeutic Advances in Medical Oncology
  49. Iron removal enhances vitamin C-induced apoptosis and growth inhibition of K-562 leukemic cells
    Mitsuyo Tsuma-Kaneko, Masakazu Sawanobori, Shohei Kawakami, Tomoko Uno, Yoshihiko Nakamura, Makoto Onizuka, Kiyoshi Ando, Hiroshi Kawada · 2018 · Scientific Reports
  50. Synergistic binding of actinomycin D and echinomycin to DNA mismatch sites and their combined anti-tumour effects
    Roshan Satange, Chih-Chun Chang, Long‐Yuan Li, Sheng‐Hao Lin, Stephen Neidle, Ming‐Hon Hou · 2023 · Nucleic Acids Research
  51. Crosstalk between hypoxic cellular micro-environment and the immune system: a potential therapeutic target for infectious diseases
    Olalekan Chris Akinsulie, Sammuel Shahzad, Seto Charles Ogunleye, Ifeoluwa Peace Oladapo, Melina Joshi, Charles Egede Ugwu, Joy Olaoluwa Gbadegoye, Fasilat Oluwakemi Hassan, Richard Ayomide Adeleke, Qudus Afolabi Akande et al. · 2023 · Frontiers in Immunology
  52. Differential inflammatory conditioning of the bone marrow by acute myeloid leukemia and its impact on progression
    Valentina R. Minciacchi, Christina Karantanou, Jimena Bravo, Raquel S. Pereira, Costanza Zanetti, Theresa Krack, Rahul Kumar, Katrin Bankov, Sylvia Hartmann, Brian J.P. Huntly et al. · 2024 · Blood Advances
  53. Hypoxia-Mediated Regulation of Stem Cell Fate
    Rashim Pal Singh, Kristin Franke, Ben Wielockx · 2012 · High Altitude Medicine & Biology
  54. Hif-1α Deletion May Lead to Adverse Treatment Effect in a Mouse Model of MLL-AF9-Driven AML
    Talia Velasco-Hernandez, S. Soneji, I. Hidalgo, Eva Erlandsson, J. Cammenga, D. Bryder · 2018 · Stem Cell Reports
  55. Sustain, Adapt, and Overcome—Hypoxia Associated Changes in the Progression of Lymphatic Neoplasia
    Orsolya Matolay, Gábor Méhes · 2019 · Frontiers in Oncology
  56. Hypoxic stress and hypoxia-inducible factors in leukemias
    Daniela Magliulo, Rosa Bernardi · 2022 · Frontiers in Oncology
  57. Biomedical engineering targeting cancer stem cells to reinforce cancer therapy
    Shumin Sun, Nailin Yang, Zifan Pei, Fei Gong, Liang Cheng · 2025 · Coordination Chemistry Reviews
  58. Overexpression of hypoxia‐inducible factor 1 alpha impacts FoxP3 levels in mycosis fungoides—Cutaneous T‐cell lymphoma: Clinical implications
    Marcela Alcántara‐Hernández, Carmen Torres-Zárate, Gibrán Pérez‐Montesinos, Fermín Jurado‐Santa Cruz, María Antonieta Domínguez-Gómez, Amelia Peniche-Castellanos, Eduardo Antonio Ferat-Osorio, Natividad Neri, M. Jesús Nambo, Isabel Alvarado‐Cabrero et al. · 2013 · International Journal of Cancer
  59. The secrets of the bone marrow niche: Metabolic priming for AML
    Rushdia Zareen Yusuf, Yinghua Wang, David T. Scadden · 2012 · Nature Medicine
  60. Hypoxic, glycolytic metabolism is a vulnerability of B-acute lymphoblastic leukemia-initiating cells
    Vivian Morris, Dahai Wang, Zhiheng Li, William Marion, Travis K. Hughes, Patricia Sousa, Taku Harada, Shannan Ho Sui, Sergey Naumenko, Jérémie Kalfon et al. · 2022 · Cell Reports
  61. The Anti-Leukemia Effect of Ascorbic Acid: From the Pro-Oxidant Potential to the Epigenetic Role in Acute Myeloid Leukemia
    Serena Travaglini, Carmelo Gurnari, Silvia Antonelli, Giorgia Silvestrini, Nélida I. Noguera, Tiziana Ottone, Maria Teresa Voso · 2022 · Frontiers in Cell and Developmental Biology
  62. Hypoxia-inducible factor 1a is a Tsc1-regulated survival factor in newborn neurons in tuberous sclerosis complex
    David M. Feliciano, Shiliang Zhang, Jennifer L. Quon, Angélique Bordey · 2013 · Human Molecular Genetics
  63. Hypoxia inducible factor 1α expression and effects of its inhibitors in canine lymphoma
    Satoshi Kambayashi, Masaya Igase, Kosuke Kobayashi, Ayana KIMURA, Takako SHIMOKAWA MIYAMA, Kenji Baba, Shunsuke Noguchi, Takuya Mizuno, Masaru Okuda · 2015 · Journal of Veterinary Medical Science
  64. Theragnostic strategies harnessing the self-renewal pathways of stem-like cells in the acute myeloid leukemia
    Rahul Bhattacharjee, Sharad Ghosh, Arijit Nath, Asmita Basu, Ojaswi Biswas, Chandragauda R Patil, Chanakya Nath Kundu · 2022 · Critical Reviews in Oncology/Hematology
  65. Autocrine/paracrine erythropoietin regulates migration and invasion potential and the stemness of human breast cancer cells
    Ke Liang, Songbo Qiu, Yang Lü · 2013 · Cancer Biology & Therapy
  66. Molecular signatures of chronic myeloid leukemia stem cells
    Yaoyu Chen, Shaoguang Li · 2013 · Biomarker Research
  67. A Hypoxia-Associated Prognostic Gene Signature Risk Model and Prognosis Predictors in Gliomas
    Feng Gao, Zhengzheng Wang, Jiajie Gu, Xiaojia Zhang, Huixiao Wang · 2021 · Frontiers in Oncology
  68. ChREBP promotes the differentiation of leukemia-initiating cells to inhibit leukemogenesis through the TXNIP/RUNX1 pathways
    Hong-Xiang Zeng, Hao Gu, Chi-Qi Chen, Minle Li, Fangzhen Xia, Li Xie, Xiao-Ye Liu, Feifei Zhang, X. Tong, Jiang-Bo Wang et al. · 2016 · OncoTarget
  69. Isolation, Maintenance and Expansion of Adult Hematopoietic Stem/Progenitor Cells and Leukemic Stem Cells
    Isabella Maria Mayer, Andrea Hoelbl‐Kovacic, Veronika Sexl, Eszter Doma · 2022 · Cancers
  70. Macro-scale, scaffold-assisted model of the human bone marrow endosteal niche using hiPSC-vascularized osteoblastic organoids
    Qing Li, Marina Tsvetomilova Nikolova, Gangyu Zhang, Igor Červenka, Federica Valigi, Dominik Bürri, Evelia Plantier, Andrea Mazzoleni, Anaïs Lamouline, Juerg Schwaller et al. · 2025 · Cell stem cell
  71. Integrative single‐cell expression and functional studies unravels a sensitization to cytarabine‐based chemotherapy through HIF pathway inhibition in AML leukemia stem cells
    Talía Velasco-Hernández, Juan L. Trincado, Meritxell Vinyoles, Adrià Closa, Alba Martínez‐Moreno, Francisco Gutiérrez‐Agüera, Òscar Molina, Virginia Rodríguez-Cortez, Pau Ximeno-Parpal, Narcís Fernández‐Fuentes et al. · 2024 · HemaSphere
  72. Insights into the mechanism of Arnebia euchroma on leukemia via network pharmacology approach
    Biting Wang, Zengrui Wu, Jiye Wang, Weihua Li, Guixia Liu, Bo Zhang, Yun Tang · 2020 · BMC Complementary Medicine and Therapies
  73. PRC2 mediated KLF2 down regulation: a therapeutic and diagnostic axis during tumor progression
    Negin Taghehchian, Amirhosein Maharati, Iman Akhlaghipour, Amir Sadra Zangouei, Meysam Moghbeli · 2023 · Cancer Cell International
  74. Inhibition of BMK1 pathway suppresses cancer stem cells through BNIP3 and BNIP3L
    Chengli Song, Qiang Xu, Kui Jiang, Guangyu Zhou, Xuebin Yu, Lina Wang, Yuting Zhu, Liping Fang, Zhe Si Yu, Jiing‐Dwan Lee et al. · 2015 · Oncotarget
  75. Molecular and cellular toxicological profiling of DNA bis-intercalator, quinoxaline compounds: echinomycin as the versatile lead
    Yoon Sun Park, Woon‐Seob Shin, Cheol-Su Kim, Chan Mug Ahn, Xu-Feng Qi, Soo‐Ki Kim · 2018 · Molecular & Cellular Toxicology
  76. The arginase inhibitor Nω−hydroxy−nor−arginine (nor−NOHA) induces apoptosis in leukemic cells specifically under hypoxic conditions but CRISPR/Cas9 excludes arginase 2 (ARG2) as the functional target
    King Pan Ng, Aditi Manjeri, Lin Ming Lee, Zhu En Chan, Chin Yee Tan, Qiancheng Darren Tan, A'Qilah Majeed, Kian Leong Lee, Charles T. H. Chuah, Toshio Suda et al. · 2018 · PLoS ONE
  77. PLC‐β2 is modulated by low oxygen availability in breast tumor cells and plays a phenotype dependent role in their hypoxia‐related malignant potential
    Federica Brugnoli, Silvia Grassilli, Yasamin Al‐Qassab, Silvano Capitani, Valeria Bertagnolo · 2016 · Molecular Carcinogenesis
  78. Distinct human stem cell subpopulations drive adipogenesis and fibrosis in musculoskeletal injury
    Steven M. Garcia, Justin Lau, Agustin Diaz, Hannah M. Chi, Miguel A. Lizarraga, Aboubacar Wague, Cristhian F. Montenegro, Michael Davies, Xuhui Liu, Brian Thomas Feeley · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  79. Associations between HIFs and tumor immune checkpoints: mechanism and therapy
    Liu, Jiayu, Jiang, Ying, Chen, Lingyan, Qian, Zhiwen, Zhang, Yan · 2024 · Discover Oncology
  80. Systemically Administered Reovirus-Induced Downregulation of Hypoxia Inducible Factor-1α in Subcutaneous Tumors
    Takuma Hotani, Hiroyuki Mizuguchi, Fuminori Sakurai · 2018 · Molecular Therapy — Oncolytics
  81. Molecular regulation of hypoxia through the lenses of noncoding RNAs and epitranscriptome
    Safirul Islam, Chandrama Mukherjee · 2022 · Wiley Interdisciplinary Reviews - RNA
  82. Targeting Tumor Microenvironments for Cancer Prevention and Therapy
    Li V. Yang, R. Castellone, Li-Xue Dong · 2012 · InTech eBooks
  83. Synthesis and Antiproliferative Activity Evaluation of the Disulfide-Containing Cyclic Peptide Thiochondrilline C and Derivatives
    Mohana Rao Vippila, Phuong Kim Ly, Gregory D. Cuny · 2015 · Journal of Natural Products
  84. Targeting cancer stem cell plasticity and tumor microenvironment crosstalk: a comprehensive review
    Mutaz Jamal Al‐Khreisat, Waleed K. Abdulsahib, Ihsan Khudhair Jasim · 2025 · Discover Oncology
  85. Meis1, Hi1α, and GATA1 are integrated into a hierarchical regulatory network to mediate primitive erythropoiesis
    Hsin‐Yu Chung, Bo‐An Lin, Yi‐Xuan Lin, Chen‐Wei Chang, Wen‐Shyong Tzou, Tun‐Wen Pei, Chin‐Hwa Hu · 2021 · The FASEB Journal
  86. Mutations in MLL3 promote breast cancer progression via HIF1α-dependent intratumoral recruitment and differentiation of regulatory T cells
    Marie Boutet, Kenta Nishitani, Nicole Couturier, Piril Erler, Zheng Zhang, Anna Maria Militello, Marcelo Coutinho de Miranda, Emeline Barbieux, Erik Guillen, Jianmei Wu Leavenworth et al. · 2025 · Immunity
  87. Quinomycin A reduces cyst progression in polycystic kidney disease
    Priyanka S. Radadiya, Mackenzie M. Thornton, Emily A. Daniel, Jessica Y. Idowu, Wei Wang, Brenda S. Magenheimer, Dharmalingam Subramaniam, Pamela Vivian Tran, James P. Calvet, Darren P. Wallace et al. · 2021 · The FASEB Journal
  88. The Historical Relationship Between Meis1 and Leukemia
    Neslihan Meriç, Fatih Kocabaş · 2022 · Advances in experimental medicine and biology
  89. Lysosome-mediated chemoresistance in acute myeloid leukemia
    Laia Cuesta‐Casanovas, Jennifer Delgado-Martínez, Josep María Cornet-Masana, Josep Maria Casasa i Carbo, Lise Clément-Demange, Ruth M. Risueño · 2022 · Cancer Drug Resistance
  90. The transcription factor HIF2α partakes in the differentiation block of acute myeloid leukemia
    Daniela Magliulo, Matilde Simoni, Carolina Caserta, Cristina Fracassi, Serena Belluschi, Kety Giannetti, Raffaella Pini, Ettore Zapparoli, Stefano Beretta, Martina Uggé et al. · 2023 · EMBO Molecular Medicine
  91. Systemic chemotherapy promotes HIF‐1α‐mediated glycolysis and IL‐17F pathways in cutaneous T‐cell lymphoma
    Bo Wang, Kejia Li, Honglin Wang · 2020 · Experimental Dermatology
  92. Far from Health: The Bone Marrow Microenvironment in AML, A Leukemia Supportive Shelter
    Stephanie Sendker, Katharina Waack, Dirk Reinhardt · 2021 · Children
  93. The Molecular Role of HIF1α Is Elucidated in Chronic Myeloid Leukemia
    Vivek Kumar Singh, Ranjana Singh, Rashmi Kushwaha, Shailendra Prasad Verma, Anil Kumar Tripathi, Abbas Ali Mahdi · 2022 · Frontiers in Oncology
  94. Epigenetic regulation of stem cells in lung cancer oncogenesis and therapy resistance
    Jiayang Wu, Jiaming Feng, Qiran Zhang, Yazhou He, Chuan Shan Xu, Chengdi Wang, Weimin Li · 2023 · Frontiers in Genetics
  95. Leukemia Stem Cells in the Pathogenesis, Progression, and Treatment of Acute Myeloid Leukemia
    Kanak Joshi, Lei Zhang, Peter Breslin, Jiwang Zhang · 2019 · Advances in experimental medicine and biology
  96. Echinomycin: A Journey of Challenges
    Zainab Lafi, Walhan Alshaer, Ma’mon M. Hatmal, Malek Zihlif, Nisreen Asha, Hiba Abdelnabi, Abdullah Awidi · 2023 · Jordan Journal of Pharmaceutical Sciences
  97. Mesenchymal Stem Cells: Pivotal Players in Hematopoietic Stem Cell Microenvironment
    Sanaa El Marsafy · 2014 · Journal of Stem Cell Research & Therapy
  98. Cancer Stem Cells as a Target Population for Drug Discovery
    Claire Bouvard, Colleen Barefield, Shoutian Zhu · 2014 · Future Medicinal Chemistry
  99. JUN mediates glucocorticoid resistance by stabilizing HIF1a in T cell acute lymphoblastic leukemia
    Zhijie Zhang, Jiangzhou Shi, Qifang Wu et al. · 2023 · iScience
  100. Redox signalling regulates breast cancer metastasis via phenotypic and metabolic reprogramming due to p63 activation by HIF1α
    Zuen Ren, Malindrie Dharmaratne, Huizhi Liang, Outhiriaradjou Benard, Miriam Morales-Gallego, Kimita Suyama, Viney Kumar, Atefeh Taherian Fard, Ameya S Kulkarni, Michael B. Prystowsky et al. · 2024 · British Journal of Cancer